A dual strategy to improve psychotic patients’ compliance using sustained release quetiapine oral disintegrating tablets
Quetiapine (QT) is a short acting atypical antipsychotic drug effective in schizophrenia and bipolar disorder. This study aims at designing a novel dosage form of sustained release taste-masked QT orally disintegrating tablets (ODTs) based on solid lipid micro-pellets (SLMPs). QT SLMPs were prepared...
Saved in:
Main Authors: | Refaat Ahmed, Sokar Magda, Ismail Fatma, Boraei Nabila |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2016-12-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.1515/acph-2016-0041 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risperidone oral disintegrating mini-tablets: A robust-product for pediatrics
by: El-Say Khalid M., et al.
Published: (2015-12-01) -
Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods
by: Kashiwagura Yasuharu, et al.
Published: (2023-03-01) -
Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach
by: Gavan Alexandru, et al.
Published: (2017-03-01) -
Development and evaluation of orally disintegrating tablets containing the mosapride resin complex
by: Wu Tong, et al.
Published: (2018-06-01) -
Influence of fused deposition modelling printing parameters on tablet disintegration times: a design of experiments study
by: Kreft Klemen, et al.
Published: (2023-09-01)